Literature DB >> 1371885

Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.

S Komoly1, L D Hudson, H D Webster, C A Bondy.   

Abstract

To investigate insulin-like growth factor I (IGF-I) and IGF-I receptor gene expression during experimental demyelination and myelin regeneration, young mice were fed cuprizone (( bis(cyclohexanone) oxaldihydrazone )). This copper-chelating agent produces demyelination in the corpus callosum and superior cerebellar peduncles, and when treatment is stopped, there is rapid remyelination. At intervals during cuprizone treatment and recovery, brain sections were hybridized with specific probes and immunostained with antibodies to determine the localization and relative amounts of IGF-I and IGF-I receptor mRNAs and peptides. In untreated littermates, IGF-I and IGF-I receptor mRNAs and peptides were not detected in white matter. In cuprizone-treated mice, high levels of both IGF-I mRNA and peptide were expressed by astrocytes in areas of myelin breakdown. Astrocyte IGF-I expression decreased rapidly during recovery and oligodendroglial expression of myelin-related genes increased. In severely demyelinated areas, immature oligodendroglia exhibited a transient increase in IGF-I receptor mRNA and peptide immunoreactivity during early recovery. This highly specific pattern of IGF-I induction in astrocytes during demyelination and the expression of the IGF-I receptor in regenerating oligodendrocytes during recovery suggest that IGF-I functions in the regulation of oligodendrocyte and myelin metabolism in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371885      PMCID: PMC48560          DOI: 10.1073/pnas.89.5.1894

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.

Authors:  W H Daughaday; P Rotwein
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

2.  Image analysis for all.

Authors:  P R Lennard
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

Review 3.  Signal transmission by the insulin-like growth factors.

Authors:  M P Czech
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

Review 4.  The nature and regulation of the receptors for insulin-like growth factors.

Authors:  M M Rechler; S P Nissley
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

5.  Growth enhancement of transgenic mice expressing human insulin-like growth factor I.

Authors:  L S Mathews; R E Hammer; R R Behringer; A J D'Ercole; G I Bell; R L Brinster; R D Palmiter
Journal:  Endocrinology       Date:  1988-12       Impact factor: 4.736

6.  Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases.

Authors:  D A Bakker; S K Ludwin
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

7.  Alternative splicing accounts for the four forms of myelin basic protein.

Authors:  F de Ferra; H Engh; L Hudson; J Kamholz; C Puckett; S Molineaux; R A Lazzarini
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

8.  Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development.

Authors:  F A McMorris; T M Smith; S DeSalvo; R W Furlanetto
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  Differential expression of insulin-like growth factor genes in rat central nervous system.

Authors:  P Rotwein; S K Burgess; J D Milbrandt; J E Krause
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

10.  Effects of insulin and insulin-like growth factor (IGF-I) on oligodendrocyte-enriched glial cultures.

Authors:  R H van der Pal; J W Koper; L M van Golde; M Lopes-Cardozo
Journal:  J Neurosci Res       Date:  1988-04       Impact factor: 4.164

View more
  43 in total

1.  Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma.

Authors:  M Rostworowski; V Balasingam; S Chabot; T Owens; V W Yong
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

Review 2.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

3.  17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss.

Authors:  Lorelei C Taylor; Kasturi Puranam; Wendy Gilmore; Jenny P-Y Ting; Glenn K Matsushima
Journal:  Neurobiol Dis       Date:  2010-03-27       Impact factor: 5.996

4.  Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.

Authors:  LiPing Liu; Lindsey Darnall; Taofang Hu; Karen Choi; Thomas E Lane; Richard M Ransohoff
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

5.  Epimedium flavonoids ameliorate neuropathological changes and increases IGF-1 expression in C57BL/6 mice exposed to cuprizone.

Authors:  Mengru Liang; Yongyan Chen; Li Zhang; Lin Li; Guangliang Chen; Linlin Yin
Journal:  Neurochem Res       Date:  2015-02-07       Impact factor: 3.996

6.  Insulin-like growth factor-I ameliorates demyelination induced by tumor necrosis factor-alpha in transgenic mice.

Authors:  Ping Ye; George Kollias; A Joseph D'Ercole
Journal:  J Neurosci Res       Date:  2007-03       Impact factor: 4.164

Review 7.  Glial lineages and myelination in the central nervous system.

Authors:  A Compston; J Zajicek; J Sussman; A Webb; G Hall; D Muir; C Shaw; A Wood; N Scolding
Journal:  J Anat       Date:  1997-02       Impact factor: 2.610

Review 8.  Transplanting oligodendrocyte progenitors into the adult CNS.

Authors:  R J Franklin; W F Blakemore
Journal:  J Anat       Date:  1997-01       Impact factor: 2.610

9.  A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: the janus face of the kinesin light-chain 1 56836CC genetic variant.

Authors:  Zoltan Szolnoki; Andras Kondacs; Yvette Mandi; Ferenc Somogyvari
Journal:  Neuromolecular Med       Date:  2007-10-13       Impact factor: 3.843

10.  Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.

Authors:  D L Yao; X Liu; L D Hudson; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.